rituximab
biogen,roche
[]
are we screening &amp; tx approp. for hbv in #iim?
abstr #1864 found:
- 78% iim pts were screened for hbv (mean time 21 months from time of dx)
- 73% hep b core ab+ on rtx received ppx tx
- iim pts hep b core ab+ % +myositis spec ab and reach remission w/ ivig #acr22 
Immunology & Rheumatology Fellow @StanfordMed| IM Residency @UTMBHealth |@McGovernMed & @EmoryUniversity Alum | Tweets are my own